ATE481115T1 - Hämostatische vorrichtungen und zusammensetzungen aus oxidierter zellulosepartikel und ein polysaccharid bindemittel - Google Patents

Hämostatische vorrichtungen und zusammensetzungen aus oxidierter zellulosepartikel und ein polysaccharid bindemittel

Info

Publication number
ATE481115T1
ATE481115T1 AT04253808T AT04253808T ATE481115T1 AT E481115 T1 ATE481115 T1 AT E481115T1 AT 04253808 T AT04253808 T AT 04253808T AT 04253808 T AT04253808 T AT 04253808T AT E481115 T1 ATE481115 T1 AT E481115T1
Authority
AT
Austria
Prior art keywords
compositions
oxidized cellulose
cellulose particles
hemostatic devices
polysaccharide binder
Prior art date
Application number
AT04253808T
Other languages
English (en)
Inventor
Dwayne Lee Looney
Kenneth Troger
Bruce Lamb
Benjamin Walthall
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Application granted granted Critical
Publication of ATE481115T1 publication Critical patent/ATE481115T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0095—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT04253808T 2003-06-25 2004-06-25 Hämostatische vorrichtungen und zusammensetzungen aus oxidierter zellulosepartikel und ein polysaccharid bindemittel ATE481115T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/603,320 US20040265371A1 (en) 2003-06-25 2003-06-25 Hemostatic devices and methods of making same

Publications (1)

Publication Number Publication Date
ATE481115T1 true ATE481115T1 (de) 2010-10-15

Family

ID=33435338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04253808T ATE481115T1 (de) 2003-06-25 2004-06-25 Hämostatische vorrichtungen und zusammensetzungen aus oxidierter zellulosepartikel und ein polysaccharid bindemittel

Country Status (7)

Country Link
US (2) US20040265371A1 (de)
EP (1) EP1493451B1 (de)
JP (1) JP4920177B2 (de)
CN (1) CN100384489C (de)
AT (1) ATE481115T1 (de)
DE (1) DE602004029118D1 (de)
ES (1) ES2349775T3 (de)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7637948B2 (en) 1997-10-10 2009-12-29 Senorx, Inc. Tissue marking implant
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US20080039819A1 (en) * 2006-08-04 2008-02-14 Senorx, Inc. Marker formed of starch or other suitable polysaccharide
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US20090030309A1 (en) 2007-07-26 2009-01-29 Senorx, Inc. Deployment of polysaccharide markers
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US6725083B1 (en) 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
CA2659484C (en) 2000-11-20 2013-01-08 Senorx, Inc. Tissue site markers for in vivo imaging
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
CN102091347A (zh) 2004-10-20 2011-06-15 伊西康公司 可吸收的止血物
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
FR2889449B1 (fr) * 2005-08-05 2011-06-10 Khorionyx Preparations implantables
US8052658B2 (en) 2005-10-07 2011-11-08 Bard Peripheral Vascular, Inc. Drug-eluting tissue marker
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
US8064987B2 (en) 2006-10-23 2011-11-22 C. R. Bard, Inc. Breast marker
EP3542748B1 (de) 2006-12-12 2023-08-16 C. R. Bard, Inc. Gewebemarker mit mehreren bildgebungsmodi
EP2101670B1 (de) 2006-12-18 2013-07-31 C.R.Bard, Inc. Biopsiemarker mit in situ erzeugten bildgebungseigenschaften
CN101121041A (zh) * 2007-08-09 2008-02-13 美国淀粉医疗公司 变性淀粉可吸收性止血材料及其制备方法
US20090062233A1 (en) 2007-08-09 2009-03-05 Xin Ji Modified starch material of biocompatible hemostasis
US8557874B2 (en) * 2007-11-26 2013-10-15 Epic Wound Care, Inc. Hemostatic material
US8158155B2 (en) * 2007-12-20 2012-04-17 Kimberly-Clark Worldwide, Inc. Odor control cellulose-based granules
US8311610B2 (en) 2008-01-31 2012-11-13 C. R. Bard, Inc. Biopsy tissue marker
WO2009123903A1 (en) 2008-04-03 2009-10-08 Zymogenetics, Inc. Hemostatic microspheres
US9271706B2 (en) 2008-08-12 2016-03-01 Covidien Lp Medical device for wound closure and method of use
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
US9889230B2 (en) * 2008-10-17 2018-02-13 Covidien Lp Hemostatic implant
CA2742765C (en) 2008-12-30 2016-04-12 C.R. Bard Inc. Marker delivery device for tissue marker placement
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
CA2760201C (en) 2009-05-04 2019-11-19 Oregon Biomedical Engineering Institute, Inc. Hemorrhage control devices and methods
US9512237B2 (en) 2009-05-28 2016-12-06 Gp Cellulose Gmbh Method for inhibiting the growth of microbes with a modified cellulose fiber
US9512563B2 (en) 2009-05-28 2016-12-06 Gp Cellulose Gmbh Surface treated modified cellulose from chemical kraft fiber and methods of making and using same
MX382645B (es) 2009-05-28 2025-03-13 Gp Cellulose Gmbh Celulosa modificada a partir de fibra kraft química y métodos para elaborarla y su uso.
US9511167B2 (en) 2009-05-28 2016-12-06 Gp Cellulose Gmbh Modified cellulose from chemical kraft fiber and methods of making and using the same
US8470355B2 (en) * 2009-10-01 2013-06-25 Covidien Lp Mesh implant
WO2011090410A1 (en) * 2010-01-19 2011-07-28 Sca Hygiene Products Ab Absorbent article comprising an absorbent porous foam
US20120053619A1 (en) * 2010-08-31 2012-03-01 Boston Scientific Scimed, Inc. Hemostatic compositions and methods of making and using same
US9084602B2 (en) 2011-01-26 2015-07-21 Covidien Lp Buttress film with hemostatic action for surgical stapling apparatus
US9623223B2 (en) 2011-02-16 2017-04-18 Revmedx, Inc. Wound dressings comprising a plurality of liquid-expandable articles
US20120209232A1 (en) 2011-02-16 2012-08-16 Andrew Barofsky Wound stasis dressing for large surface wounds
CN103998210A (zh) * 2011-09-29 2014-08-20 聚合物器官股份有限公司 用于制备具有受控颗粒分布的合成泡沫的方法
US9028851B2 (en) * 2011-12-21 2015-05-12 Ethicon, Inc. Hemostatic materials and devices with galvanic particulates
US8815832B2 (en) * 2012-05-25 2014-08-26 Ethicon, Inc. Oxidized regenerated cellulose hemostatic powders and methods of making
JP6298468B2 (ja) 2012-10-16 2018-03-20 サーモディクス，インコーポレイテッド 創傷充填デバイスおよび方法
CN105143547B (zh) 2013-03-15 2018-05-01 Gp 纤维素股份有限公司 具有增高羧基含量的低粘度牛皮纸纤维及其制造和使用方法
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
EP3169379B1 (de) 2014-07-18 2020-07-15 Ethicon, Inc. Kombinationscellulosematerial sowie verfahren zur herstellung und verwendung
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
CN104324408B (zh) * 2014-09-25 2016-05-18 沈丽青 复合生物止血修复医用胶冲洗液的处方及制备方法
US10184011B2 (en) 2014-10-31 2019-01-22 Core Scientific Creations Ltd. Hemostatic devices with improved properties and methods of making same
HK1246653A1 (zh) 2014-11-17 2018-09-14 Context Biopharma Inc. 奥那司酮延长释放组合物和方法
US11382731B2 (en) 2015-02-27 2022-07-12 Covidien Lp Medical devices with sealing properties
JP6759335B2 (ja) * 2015-05-06 2020-09-23 ジャイラス・エーシーエムアイ・インコーポレーテッド カルボキシメチルキトサンスポンジ配合物
WO2017030908A1 (en) 2015-08-14 2017-02-23 Ethicon, Inc. Method of treating a disease using a glycolytic dependent compound
US10308676B2 (en) 2015-09-25 2019-06-04 Context Biopharma Inc. Methods of making onapristone intermediates
NZ741447A (en) * 2015-11-06 2022-12-23 Ethicon Inc Compacted hemostatic cellulosic aggregates
JP6862441B2 (ja) 2015-11-08 2021-04-21 オムリックス・バイオファーマシューティカルズ・リミテッドＯｍｒｉｘ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． セルロース系短尺繊維及び長尺繊維の止血混合物
EP3389632A4 (de) 2015-12-15 2019-11-06 Context Biopharma Inc. Amorphe onapristonzusammensetzungen und verfahren zur herstellung davon
EP3248578A1 (de) * 2016-05-24 2017-11-29 Biocer-Entwicklungs-GmbH Hämostaseeinheit und anordnung damit
CN107754005B (zh) * 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
US11413335B2 (en) * 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
CN106421875B (zh) * 2016-11-15 2019-08-27 广州迈普再生医学科技股份有限公司 可降解吸收的止血纤维材料及其制备方法和止血纤维制品
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection
EP4218844A1 (de) * 2018-01-12 2023-08-02 Boston Scientific Scimed, Inc. Pulver für hämostase
CN110732037B (zh) 2018-07-20 2023-05-26 广州倍绣生物技术有限公司 止血糊剂及其制备方法
IL262716A (en) 2018-11-01 2018-11-29 Omrix Biopharmaceuticals Ltd Oxidized cellulose preparations
IL268572A (en) 2019-08-07 2019-09-26 Omrix Biopharmaceuticals Ltd An expandable hemostatic composed of oxidized cellulose
KR102886728B1 (ko) 2019-10-31 2025-11-14 주식회사 삼양홀딩스 분말형 지혈제 조성물 및 이의 제조 방법
US20210228765A1 (en) * 2020-01-28 2021-07-29 Becton, Dickinson And Company Self-activating catheter insertion site dressing
JP6997890B2 (ja) * 2020-02-07 2022-01-18 花王株式会社 皮膚外用組成物
KR102405984B1 (ko) * 2020-02-07 2022-06-08 카오카부시키가이샤 피부 외용 조성물
CN114681659B (zh) * 2020-12-31 2023-04-18 广州迈普再生医学科技股份有限公司 复合止血粉及其制备方法和应用
CN114272445B (zh) * 2021-12-06 2023-02-03 盐城工学院 一种可用于体外和体内的止血防粘连材料及其制备方法

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517772A (en) * 1945-05-11 1950-08-08 Parke Davis & Co Neutralized oxidized cellulose products
US2914444A (en) * 1950-12-12 1959-11-24 David F Smith Cellulosic hemostatic composition
US2773000A (en) * 1952-06-06 1956-12-04 Johnson & Johnson Hemostatic surgical dressings
GB942305A (en) 1958-12-23 1963-11-20 Parachem Corp Improvements in or relating to antiseptic film and method and apparatus for producing the same
US3364200A (en) * 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
NL262878A (de) 1960-03-28
US3328259A (en) * 1964-01-08 1967-06-27 Parachem Corp Dressing for a wound containing a hemostatic agent and method of treating a wound
US3328529A (en) * 1964-08-31 1967-06-27 Heath Co Phase shifting circuit for fm stereo receiver
US3868955A (en) * 1973-10-05 1975-03-04 Personal Products Co Aldehyde polysaccharide dressings
US4289824A (en) * 1977-04-22 1981-09-15 Avtex Fibers Inc. High fluid-holding alloy rayon fiber mass
DE3037513C2 (de) * 1980-10-03 1983-05-05 Steffan, Wolfgang, 8425 Neustadt Kollagene Wundauflage
IN159332B (de) 1983-01-28 1987-05-02 Jai Mangal Sinha Thunuguntla
JPS6087225A (ja) 1983-10-18 1985-05-16 Unitika Ltd フイブリン形成促進材料の製造法
US4600574A (en) * 1984-03-21 1986-07-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of producing a tissue adhesive
US4626253A (en) 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
CS253042B1 (en) * 1985-09-25 1987-10-15 Maxmilian Mozisek Haemostatical material
ATE84961T1 (de) 1986-08-25 1993-02-15 Goodrich Co B F Wundverband und verfahren zu seiner herstellung.
US4840626A (en) * 1986-09-29 1989-06-20 Johnson & Johnson Patient Care, Inc. Heparin-containing adhesion prevention barrier and process
US4752466A (en) * 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
US5185179A (en) 1988-10-11 1993-02-09 Semiconductor Energy Laboratory Co., Ltd. Plasma processing method and products thereof
ZA899326B (en) 1988-12-07 1991-08-28 Johnson & Johnson Patient Care Low molecular weight heparin,heparinoid and hexuronyl hexosaminoglycan sulfate containing adhesion prevention barrier and process
US5134229A (en) * 1990-01-12 1992-07-28 Johnson & Johnson Medical, Inc. Process for preparing a neutralized oxidized cellulose product and its method of use
CN1035803C (zh) 1990-07-24 1997-09-10 中国化工进出口总公司 可溶性止血织物
US5180398A (en) * 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
US6066773A (en) 1993-03-22 2000-05-23 E. R. Squibb & Sons, Inc. Thin film dressing with absorbent border
GB2280850B (en) 1993-07-28 1997-07-30 Johnson & Johnson Medical Absorbable composite materials for use in the treatment of periodontal disease
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
AU1086795A (en) * 1993-11-03 1995-05-23 Clarion Pharmaceuticals, Inc. Hemostatic patch
US5660854A (en) 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
WO1996040033A1 (en) 1995-06-07 1996-12-19 Clarion Pharmaceuticals Inc. Non-biological patch for hemostasis
JPH0951912A (ja) 1995-08-11 1997-02-25 Sekisui Plastics Co Ltd 吸収体
JP2791317B2 (ja) * 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
US5945319A (en) * 1996-04-25 1999-08-31 Medtronic, Inc. Periodate oxidative method for attachment of biomolecules to medical device surfaces
US5925552A (en) * 1996-04-25 1999-07-20 Medtronic, Inc. Method for attachment of biomolecules to medical devices surfaces
US5821343A (en) * 1996-04-25 1998-10-13 Medtronic Inc Oxidative method for attachment of biomolecules to surfaces of medical devices
IN192791B (de) 1996-06-28 2004-05-22 Johnson & Johnson Medical
US6500777B1 (en) * 1996-06-28 2002-12-31 Ethicon, Inc. Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
GB2314840B (en) 1996-06-28 2000-09-06 Johnson & Johnson Medical Oxidized oligosaccharides and pharmaceutical compositions
GB2314842B (en) 1996-06-28 2001-01-17 Johnson & Johnson Medical Collagen-oxidized regenerated cellulose complexes
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
GB2337201B (en) 1997-01-30 2001-02-14 Alpenstock Holdings Ltd Haemostatic aerosol composition
US6306154B1 (en) * 1997-06-18 2001-10-23 Bhk Holding Hemostatic system for body cavities
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
WO1999001166A1 (en) 1997-07-02 1999-01-14 Coloplast A/S A method for preparing a non-fibrous porous material
JP3114016B2 (ja) * 1998-05-15 2000-12-04 株式会社ホギメディカル 細胞接着促進効果を有する創傷止血材
US6261679B1 (en) * 1998-05-22 2001-07-17 Kimberly-Clark Worldwide, Inc. Fibrous absorbent material and methods of making the same
DE19851334C2 (de) * 1998-11-06 2000-09-28 Aventis Behring Gmbh Flexible Wundauflage auf Fibrinbasis und Verfahren zu ihrer Herstellung
GB2344519B (en) * 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
US6333029B1 (en) * 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US6306424B1 (en) * 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
WO2001022059A2 (en) 1999-09-18 2001-03-29 Path Tech Limited Device and method for separation and analysis of small particles
CA2384689C (en) 1999-09-27 2009-05-12 Bhk Holding Ltd. Absorptive fabric
JP3576063B2 (ja) 2000-02-22 2004-10-13 株式会社ホギメディカル 凝固蛋白質を含む可溶性創傷治癒止血セルロース繊維とその製造方法
US6627785B1 (en) 2000-02-29 2003-09-30 Virginia Commwealth University Wound dressings with protease-lowering activity
JP2001340375A (ja) 2000-05-31 2001-12-11 Toyobo Co Ltd 創傷被覆材
DE60030892T2 (de) 2000-07-04 2007-04-19 Frohwitter, Bernhard Wundverband mit einem aktiven therapeutischen agens
JP2002052077A (ja) 2000-08-07 2002-02-19 Unitika Ltd 創傷被覆材及びその製造方法
WO2002022059A1 (en) 2000-09-12 2002-03-21 Virginia Commonwealth University Treatment for high pressure bleeding
US6599323B2 (en) * 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
AR032517A1 (es) 2001-01-25 2003-11-12 Nycomed Pharma As Un metodo para preparar una esponja de colageno, un dispositivo para extraer una parte de una espuma de colageno, y una esponja de colageno alargada
US6800753B2 (en) * 2001-09-04 2004-10-05 University Of Iowa Research Foundation Regenerated cellulose and oxidized cellulose membranes as potential biodegradable platforms for drug delivery and tissue engineering
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US7252837B2 (en) * 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
GB2399289B (en) 2003-03-10 2006-03-08 Johnson & Johnson Medical Ltd Hydrocolloid materials for use in wound healing
RU2235539C1 (ru) 2003-04-25 2004-09-10 Филатов Владимир Николаевич Способ получения порошкообразного материала для остановки кровотечений

Also Published As

Publication number Publication date
EP1493451A1 (de) 2005-01-05
EP1493451B1 (de) 2010-09-15
CN1575821A (zh) 2005-02-09
JP4920177B2 (ja) 2012-04-18
JP2005015484A (ja) 2005-01-20
DE602004029118D1 (de) 2010-10-28
US20060233869A1 (en) 2006-10-19
US8709463B2 (en) 2014-04-29
US20040265371A1 (en) 2004-12-30
ES2349775T3 (es) 2011-01-11
CN100384489C (zh) 2008-04-30

Similar Documents

Publication Publication Date Title
DE602004029118D1 (de) Hämostatische Vorrichtungen und Zusammensetzungen aus oxidierter Zellulosepartikel und ein Polysaccharid Bindemittel
EP1721623A3 (de) Absorbierende Polymerzusammensetzungen, medizinische Artikeln und Verfahren
EP1992676A4 (de) Organomolybdänadditiv, herstellung davon und schmiermittelzusammensetzung, die das additiv enthält, und verwendungen davon
EP4516358A3 (de) Il-15-konjugate und verwendungen davon
DK1443912T3 (da) Sammensætninger med en kombination af umiddelbare og kontrollerede frisætningsegenskaber
EP2338332A3 (de) Hohles Glukan- oder Zellenwand-Partikel, das eine Terpenkomponente verkapselt
DE69736888D1 (de) Verfahren und zusammensetzungen zur verbesserung der bioadhäsiven eigenschaften von polymeren
DE60005994D1 (de) Verflüssigbare pulverzusammensetzungen
ATE520372T1 (de) Poröses implantat für den bandscheibennukleus- ersatz
EP3320911A3 (de) Activin-acrtrii-antagonisten und ihre verwendungen zur erhohung der erythrozytenspiegel
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
ATE428177T1 (de) Magnetorheologische fluidzusammensetzung und dieselbe benutzende knieprothese
DK1401352T3 (da) Fremgangsmåde til fremstilling af en chitosansårforbinding
EP2431385A3 (de) Kombinationstherapie mit Chlorotoxin
MA28334A1 (fr) Compositions pharmaceutiques antivirales
DE60116838D1 (de) Salicylaldehyd enthaltende Zusammensetzung mit antimikrobielle und duftende Eigenschaften und Verfahren zu ihre Verwendung
EP4563679A3 (de) Phasenstabile, sprühbare erfrischungszusammensetzungen mit suspendierten partikeln
EP2842582A3 (de) Medizinprodukte mit Silikat- und Kohlenstoffpartikeln
LTC1608344I2 (lt) Per burną vartojamos kladribino kompozicijos
DE59909854D1 (de) Partikulärer wirkstoffträger für die pulmonale applikation
WO2003024499A3 (en) Water-soluble coating for bioactive devices
EP1378255A3 (de) Hämostatischer Wundverband und Verfahren zu deren Herstellung
EP1980289A3 (de) Katheter mit weicher distaler Spitze
TW200605912A (en) Tooth-whitening compositions comprising silicone polymer and methods therefor
EP1848410A4 (de) Zusammensetzungen zur ausgabe von polymerteilchen und anwendungsverfahren dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties